Pear Therapeutics — which creates clinician-prescribed software to treat behavioral health conditions — is going public by way of a merger with a special purpose acquisition company (SPAC).  The developer of prescription digital therapeutics (PDTs) announced Tuesday that it has entered into a definitive business combination agreement with Thimble Point Acquisition Corp. (Nasdaq: THMA), a […]